Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes

This publication has 45 references indexed in Scilit:

• Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease
  Circulation, 2001
• Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study
  The Lancet, 2001
• The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes
  Atherosclerosis, 2001
• Fibrates, dyslipoproteinaemia and cardiovascular disease
  Current Opinion in Lipidology, 1999
• Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
  New England Journal of Medicine, 1999
• Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: an hypothesis
  Atherosclerosis, 1998
• Cardiovascular Outcomes in Type 2 Diabetes: A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study
  Diabetes Care, 1998
• Low-density lipoprotein size, high-density lipoprotein concentration, and endothelial dysfunction in non-insulin-dependent diabetes
  Diabetic Medicine, 1997
• Impaired Endothelium-Dependent and Independent Dilatation of Forearm Resistance Arteries in Men with Diet-Treated Non-Insulin-Dependent Diabetes: Role of Dyslipidaemia
  Clinical Science, 1996
• Oxidative Stress and Diabetic Vascular Complications
  Diabetes Care, 1996